Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates - Zacks Investment Research
Cartesian Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.92
+24% in 7d after detection
Post-detection moves
1h
—
1d
+7.1%
3d
+11%
7d
+24%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS